Changdong Liu

Changdong Liu, M.D. is currently the Chief Medical Officer (CMO) & Chief Scientific Officer (CSO) at Ocumension, a company listed on the Hong Kong Stock Exchange. Previously, Changdong held key positions at Livzon Mabpharm, Inc., Qilu Pharmaceutical Co., Ltd., Bio-Thera Solutions, and Alcon, gaining extensive experience in clinical development and clinical trial operations. With a strong educational background in biological and biomedical sciences, clinical medicine, ophthalmology, and cancer research, Changdong has a solid foundation for their leadership roles in the pharmaceutical industry.